<DOC>
	<DOCNO>NCT00142935</DOCNO>
	<brief_summary>Much HIV/AIDS epidemic driven transmission person addict opiate . Many individual pass correctional setting year , create opportunity linkage substance abuse treatment . The purpose study evaluate effectiveness initiate opiate replacement therapy prior release incarceration reduce HIV risk behavior drug relapse . In addition , study evaluate effectiveness short-term payment versus non-payment community opiate replacement therapy immediately follow release incarceration .</brief_summary>
	<brief_title>Effectiveness Opiate Replacement Therapy Administered Prior Release From Correctional Facility - 1</brief_title>
	<detailed_description>A substantial proportion individual addict heroin incarcerate addicted majority individual release correctional set history heroin addiction . The period immediately release incarceration particularly high-risk time HIV transmission problem , include drug relapse overdose . Methadone treatment widely use opiate replacement therapy United States show decrease HIV risk , well drug use , addiction relapse , criminal activity . The purpose study evaluate effectiveness initiate opiate replacement therapy prior release incarceration reduce HIV risk behavior drug relapse . In addition , study evaluate effectiveness short-term payment versus non-payment community opiate replacement therapy immediately follow release incarceration . Participants randomly assign 1 3 treatment group . Participants enrol Group 1 initiate methadone opiate replacement therapy 1 month prior release incarceration . They proceed methadone program choice upon release receive short-term payment cover treatment cost . Participants enrol Group 2 refer methadone program choice receive short-term payment cover treatment cost . Participants enrol Group 3 refer program choice upon release incarceration without receive financial assistance . All participant opportunity partake exist support program available Rhode Island Department Corrections incarcerate community upon release . Follow-up assessment occur Months 1.5 , 6 , 12 . These include interview urine specimen toxicology analysis verify self-reports .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Currently incarcerate Rhode Island Department Corrections schedule release date least 28 day enrollment Incarceration length exceed two year time enrollment Heroin dependent selfreported heroin injection month prior incarceration OR enrollment methadone treatment program prior incarceration heroin addiction history injection drug use Desire enter methadone treatment upon release plan secure fund methadone treatment study completion History prior tolerance methadone History least one drugrelated incarceration Speaks English Spanish Plans remain Rhode Island duration study ( 24 month ) Ability provide least two name individual verify participant information Currently receive methadone Rhode Island Department Corrections Currently undergo nonnarcotic detoxification illicit opiates Rhode Island Department Corrections Plans leave Rhode Island within two year follow enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>HIV Prevention</keyword>
	<keyword>Opioid-Related Disorders</keyword>
	<keyword>Medication Assisted Treatment</keyword>
	<keyword>Methadone</keyword>
</DOC>